Ambulatory 0 10 0 10 O
male 11 15 11 15 B-gender

Institutionalized 0 17 16 33 O
residents 18 27 34 43 O
with 28 32 44 48 O
subacute 33 41 49 57 O
illnesses 42 51 58 67 O
who 52 55 68 71 O
are 56 59 72 75 O
not 60 63 76 79 O
expected 64 72 80 88 O
to 73 75 89 91 O
survive 76 83 92 99 O
or 84 86 100 102 O
who 87 90 103 106 O
will 91 95 107 111 O
be 96 98 112 114 O
discharged 99 109 115 125 O
in 110 112 126 128 O
< 113 114 129 130 O
2 115 116 131 132 B-upper_bound
years 117 122 133 138 I-upper_bound

Patients 0 8 139 147 O
will 9 13 148 152 O
be 14 16 153 155 O
allowed 17 24 156 163 O
to 25 27 164 166 O
continue 28 36 167 175 O
on 37 39 176 178 O
glucocorticoids 40 55 179 194 B-treatment
and 56 59 195 198 O
anticonvulsants 60 75 199 214 B-treatment
because 76 83 215 222 O
their 84 89 223 228 O
use 90 93 229 232 O
is 94 96 233 235 O
common 97 103 236 242 O
in 104 106 243 245 O
this 107 111 246 250 O
population 112 122 251 261 O

Those 0 5 262 267 O
currently 6 15 268 277 O
on 16 18 278 280 O
therapy 19 26 281 288 B-treatment
( 27 28 289 290 O
including 28 37 290 299 O
bisphosphonate 38 52 300 314 B-treatment
, 52 53 314 315 O
denosumab 54 63 316 325 B-treatment
, 63 64 325 326 O
or 65 67 327 329 O
teriparatide 68 80 330 342 B-treatment
) 80 81 342 343 O
or 82 84 344 346 O
who 85 88 347 350 O
have 89 93 351 355 O
been 94 98 356 360 O
on 99 101 361 363 O
a 102 103 364 365 O
bisphosphonate 104 118 366 380 O
for 119 122 381 384 O
> 123 124 385 386 O
1year 125 130 387 392 B-lower_bound
during 131 137 393 399 O
the 138 141 400 403 O
previous 142 150 404 412 B-upper_bound
2 151 152 413 414 I-upper_bound
years 153 158 415 420 I-upper_bound
because 159 166 421 428 O
some 167 171 429 433 O
bisphosphonates 172 187 434 449 B-treatment
are 188 191 450 453 O
long 192 196 454 458 O
acting 197 203 459 465 O

Those 0 5 466 471 O
on 6 8 472 474 O
glucocorticoids 9 24 475 490 B-treatment
and 25 28 491 494 O
anticonvulsants 29 44 495 510 B-treatment
will 45 49 511 515 O
be 50 52 516 518 O
allowed 53 60 519 526 O
to 61 63 527 529 O
continue 64 72 530 538 O
in 73 75 539 541 O
the 76 79 542 545 O
study 80 85 546 551 O
because 86 93 552 559 O
their 94 99 560 565 O
use 100 103 566 569 O
is 104 106 570 572 O
common 107 113 573 579 O
in 114 116 580 582 O
this 117 121 583 587 O
population 122 132 588 598 O

Those 0 5 599 604 O
on 6 8 605 607 O
hormone 9 16 608 615 B-treatment
replacement 17 28 616 627 I-treatment
therapy 29 36 628 635 I-treatment
( 37 38 636 637 I-treatment
HRT 38 41 637 640 I-treatment
) 41 42 640 641 I-treatment
, 42 43 641 642 O
raloxifene 44 54 643 653 B-treatment
, 54 55 653 654 O
or 56 58 655 657 O
prescribed 59 69 658 668 B-treatment
protective 70 80 669 679 I-treatment
hip 81 84 680 683 I-treatment
pads 85 89 684 688 I-treatment
by 90 92 689 691 O
their 93 98 692 697 O
Primary 99 106 698 705 O
Care 107 111 706 710 O
Physician 112 121 711 720 O
( 122 123 721 722 O
PCP 123 126 722 725 O
) 126 127 725 726 O
will 128 132 727 731 O
be 133 135 732 734 O
allowed 136 143 735 742 O
to 144 146 743 745 O
participate 147 158 746 757 O
and 159 162 758 761 O
continue 163 171 762 770 O
on 172 174 771 773 O
these 175 180 774 779 O
therapies 181 190 780 789 B-treatment

Those 0 5 790 795 O
with 6 10 796 800 O
a 11 12 801 802 O
history 13 20 803 810 O
of 21 23 811 813 O
hypocalcemia 24 36 814 826 O
or 37 39 827 829 O
contraindication 40 56 830 846 O
for 57 60 847 850 O
treatment 61 70 851 860 B-treatment

Those 0 5 861 866 O
with 6 10 867 871 O
vitamin 11 18 872 879 B-clinical_variable
D 19 20 880 881 I-clinical_variable
levels 21 27 882 888 I-clinical_variable
< 28 29 889 890 O
25ng 30 34 891 895 B-upper_bound
/ 34 35 895 896 I-upper_bound
mL 35 37 896 898 I-upper_bound
will 38 42 899 903 O
be 43 45 904 906 O
treated 46 53 907 914 O
with 54 58 915 919 O
vitamin 59 66 920 927 O
D 67 68 928 929 O
50,000 69 75 930 936 O
IU 76 78 937 939 O
/ 78 79 939 940 O
wk 79 81 940 942 O
for 82 85 943 946 O
8 86 87 947 948 O
weeks 88 93 949 954 O

We 0 2 955 957 O
will 3 7 958 962 O
suggest 8 15 963 970 O
that 16 20 971 975 O
participants 21 33 976 988 O
stop 34 38 989 993 O
long 39 43 994 998 O
- 43 44 998 999 O
term 44 48 999 1003 O
calcitonin 49 59 1004 1014 B-clinical_variable
as 60 62 1015 1017 O
it 63 65 1018 1020 O
has 66 69 1021 1024 O
been 70 74 1025 1029 O
discontinued 75 87 1030 1042 O
in 88 90 1043 1045 O
Europe 91 97 1046 1052 O
due 98 101 1053 1056 O
to 102 104 1057 1059 O
cancer 105 111 1060 1066 B-cancer
concerns 112 120 1067 1075 O

Would 0 5 1076 1081 O
be 6 8 1082 1084 O
treated 9 16 1085 1092 O
based 17 22 1093 1098 O
on 23 25 1099 1101 O
FRAX 26 30 1102 1106 O
® 30 31 1106 1107 O
and 32 35 1108 1111 O
the 36 39 1112 1115 O
National 40 48 1116 1124 O
Osteoporosis 49 61 1125 1137 O
Foundation 62 72 1138 1148 O
( 73 74 1149 1150 O
NOF 74 77 1150 1153 O
) 77 78 1153 1154 O
treatment 79 88 1155 1164 O
thresholds 89 99 1165 1175 O
of 100 102 1176 1178 O
a 103 104 1179 1180 O
10 105 107 1181 1183 O
year 108 112 1184 1188 O
risk 113 117 1189 1193 O
of 118 120 1194 1196 O
≥ 121 122 1197 1198 O
20 123 125 1199 1201 B-lower_bound
% 125 126 1201 1202 I-lower_bound
for 127 130 1203 1206 O
a 131 132 1207 1208 O
major 133 138 1209 1214 O
fracture 139 147 1215 1223 O
or 148 150 1224 1226 O
≥ 151 152 1227 1228 O
3 153 154 1229 1230 B-lower_bound
% 154 155 1230 1231 I-lower_bound
for 156 159 1232 1235 O
hip 160 163 1236 1239 O
fracture 164 172 1240 1248 O
suing 173 178 1249 1254 O
femoral 179 186 1255 1262 O
neck 187 191 1263 1267 O
BMD 192 195 1268 1271 O

by 0 2 1272 1274 O
bone 3 7 1275 1279 O
density 8 15 1280 1287 O
[ 16 17 1288 1289 O
spine 17 22 1289 1294 O
, 22 23 1294 1295 O
hip 24 27 1296 1299 O
or 28 30 1300 1302 O
forearm 31 38 1303 1310 O
Bone 39 43 1311 1315 B-clinical_variable
Mineral 44 51 1316 1323 I-clinical_variable
Density 52 59 1324 1331 I-clinical_variable
( 60 61 1332 1333 I-clinical_variable
BMD 61 64 1333 1336 I-clinical_variable
) 64 65 1336 1337 I-clinical_variable
T 66 67 1338 1339 I-clinical_variable
- 67 68 1339 1340 I-clinical_variable
score 68 73 1340 1345 I-clinical_variable
≤ 74 75 1346 1347 O
-2.5 76 80 1348 1352 B-upper_bound
] 80 81 1352 1353 O

residents 0 9 1354 1363 O
with 10 14 1364 1368 O
osteoporosis 15 27 1369 1381 B-chronic_disease
or 28 30 1382 1384 O
low 31 34 1385 1388 B-chronic_disease
bone 35 39 1389 1393 I-chronic_disease
mass 40 44 1394 1398 I-chronic_disease
( 45 46 1399 1400 O
at 46 48 1400 1402 O
risk 49 53 1403 1407 O
for 54 57 1408 1411 O
fracture 58 66 1412 1420 O
) 66 67 1420 1421 O
ages 68 72 1422 1426 B-age
65 73 75 1427 1429 B-lower_bound
and 76 79 1430 1433 O
older 80 85 1434 1439 O

